[Form 4] BullFrog AI Holdings, Inc. Insider Trading Activity
Jason Hanson, a director of BullFrog AI Holdings, Inc. (BFRG), was granted 15,000 stock options on 09/25/2025. The options have an exercise price of $1.43 and vest on the earlier of September 25, 2026 and the date of the Company\'s annual meeting for fiscal year 2026. The options expire on September 25, 2035. The grant was made under the Company\'s 2022 Equity Compensation Plan and the lapse of forfeiture restrictions will accelerate upon a change in control or a significant financing. Following the grant, Mr. Hanson beneficially owns 15,000 options reported as direct ownership.
- 15,000 options granted to a director are explicitly disclosed, increasing transparency of insider compensation.
- Vesting schedule set for the earlier of 09/25/2026 or the 2026 annual meeting provides a defined retention period.
- Change-in-control acceleration and significant financing acceleration are disclosed, clarifying potential acceleration events.
- 10-year term (expire 09/25/2035) gives a long exercise window for the option holder.
- Potential dilution from 15,000 underlying shares is introduced, which may marginally affect existing shareholders.
- Grant price tied to market price on the grant date means immediate intrinsic value depends on market movements not disclosed here.
- Acceleration on significant financing could be triggered by financings that materially change capital structure without shareholder approval.
Insights
TL;DR: Director received a time-based option grant with change-in-control acceleration and a 10-year term.
The Form 4 discloses a non-derivative option award of 15,000 shares to Director Jason Hanson at a $1.43 exercise price, granted under the 2022 Equity Compensation Plan. Vesting is the earlier of a fixed one-year anniversary and the 2026 annual meeting, with forfeiture lapse subject to acceleration upon a change in control or a significant financing. These terms are standard for board compensation, combining short-term retention with change-in-control protection. The filing reports direct beneficial ownership of the option award. From a governance standpoint, the disclosure is routine and transparent.
TL;DR: Award size and terms are modest; 10-year expiration and market-based grant price are noted.
The reported grant of 15,000 stock options exercisable at $1.43 appears to be a typical equity retainer or incentive award for a director. The options expire on September 25, 2035, providing a long exercise window. The grant price is described as based on the market price on the grant date. Acceleration on change in control or significant financing may enhance value realization for the recipient in certain transactions. The filing contains clear exercise price, vesting trigger, expiry, and plan reference for investor review.